This Handbook brings together a groundbreaking collection of chapters that uses a gender lens to explore health, healthcare and health policy in both the Global South and North. Empirical evidence is drawn from a variety of different settings and points to the many ways in which the gendered dimensions of health have become reworked across the globe.
The Case of Independent Living
Steven DeMello and Peder Inge Furseth
There is a growing trend toward the integration of public and private entities in the delivery of public services. This book aims to improve the ability to innovate successfully in large-scale public/private endeavors. The authors develop an underpinning theory of innovation, and extend it to address key issues in public/private collaboration. As an example, they explore the subject of independent living for seniors and disabled people across four countries – the US, UK, Norway and Japan. The resulting model provides a vehicle for all major stakeholders to better understand the dynamics of innovation, which will in turn offer the opportunity to improve performance and successful adoption.
Choice, Equality and Cost
This lucid and comprehensive book explores the ways in which the State, the market and the citizen can collaborate to satisfy people’s health care needs. It argues that health care is not a commodity like any other. It asks if its unique properties mean that there is a role for social regulation and political management. Apples and oranges can be left to the buyers and the sellers. Health care may require an input from the consensus, the experts, the insurers, the politicians and the bureaucrats as well. David Reisman makes a fresh contribution to the debate. He argues that the three policy issues that are of primary importance are choice, equality and cost.
Edited by Myron D. Fottler, Donna Malvey and Donna J. Slovensky
The Handbook of Healthcare Management is a comprehensive examination of key management practices for global healthcare organizations, arguing that insight into and implementation of these practices is essential for success and sustainability.
Edited by Neil Lunt, Daniel Horsfall and Johanna Hanefeld
The growth of international travel for purposes of medical treatment has been accompanied by increased academic research and analysis. This Handbook explores the emergence of medical travel and patient mobility and the implications for patients and health systems. Bringing together leading scholars and analysts from across the globe, this unprecedented Handbook examines the regional and national experiences of medical tourism, including coverage of the Americas, Europe, Africa, the Middle East, and Asia. The chapters explore topics on issues of risk, law and ethics; and include treatment-focused discussions which highlight patient decision-making, patient experience and treatment outcomes for cosmetic, transplantation, dentil, fertility and bariatric treatment.
Ritsa Fotinatos-Ventouratos and Cary Cooper
The global economic crisis of 2008 caused the collapse of the world’s financial institutions, large-scale unemployment, the devaluing of housing stocks leading to mortgage defaults and left many countries in debt, unable to meet their financial obligations. The consequences of this in the workplace were substantial and for those who remained employed, longer working hours, heavier workloads, an insecure working environment and micro-management became manifest. Examining the impact of the recession on organizations and individuals at work, this book explores the long lasting effect the crisis will have on workplaces for the future. An insightful and thorough account of how the economic crisis has unfolded on an international scale is presented and the profound psychological impact that this recession has had on the workplace assessed.
Robert J. Brent
Cost–benefit analysis is the only method of economic evaluation that can effectively indicate whether a health care treatment or intervention is worthwhile. In this thoroughly updated and revised second edition, Robert Brent expands the scope of the field by including the latest concepts and applications throughout all regions of the world. This book attempts to strengthen the link between cost–benefit analysis and the mainstream health care evaluation field, which is dominated by non-economists. The need to build a bridge between the two is more important than ever before, as the general understanding of cost-benefit analysis appears to have regressed.
Sarah Harper, Kate Hamblin, Jaco Hoffman, Kenneth Howse and George Leeson
The International Handbook on Ageing and Public Policy explores the challenges arising from the ageing of populations across the globe for government, policy makers, the private sector and civil society. It examines various national state approaches to welfare provisions for older people, and highlights alternatives based around the voluntary and third-party sector, families and private initiatives. The Handbook is highly relevant for academics interested in this critical issue, and offers important messages for policy makers and practitioners.
Anthony J. Culyer
This third edition of Anthony Culyer’s authoritative The Dictionary of Health Economics brings the material right up to date as well as adding plentiful amounts of new information, with a number of revised definitions. There are now nearly 3,000 entries in this comprehensive work. This third edition includes 250 new references as sources for definitions and examples of practice and the bibliography comprises roughly 1,400 items. Anthony Culyer has refined and made the system of cross-references and internet links even more comprehensive than in previous editions. This Dictionary is as complete a statement as exists anywhere of what it is that every health economist ought to know.
Graham Dukes, John Braithwaite and J. P. Moloney
The pharmaceutical industry exists to serve the community, but over the years it has engaged massively in corporate crime, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health documents the problems, ranging from false advertising and counterfeiting to corruption waste and overpricing, with unacceptable pressures on doctors, politicians, patients and the media. Uniquely, the book goes on to present a realistic and worldwide solution for the future, with positive policies encouraging honest dealing as well as partial privatization of enforcement and greater emphasis on creative research to develop the medicines that society needs most.